Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2020

Jun 30, 2020

60507_rns_2020-06-30_4fd2977d-72ae-4c92-8f09-12ffc70997c9.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Limited

The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

June 30, 2020

The Corporate Relationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Pfizer Limited – Important Communication for Shareholders

Enclosed herewith please find an important communication dated June 30, 2020, by Pfizer Limited to its Shareholders with respect to claiming the unclaimed dividend, updation of e-mail ID, Bank Mandate & KYC details and transfer of shares of the shareholders who have not claimed the dividend for previous seven consecutive years (i.e., From March 31, 2013) to Ministry of Corporate Affairs IEPF Account.

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited

Prajeet Nair Company Secretary

Encl: A/a

CIN: L24231MH1950PLC008311 [email protected]

PFIZER LIMITED

CIN: L24231MH1950PLC008311

Regd. Office: The Capital, 1802 / 1901, Plot No. C – 70, G Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051 Tel: 022 6693 2000 Fax: 022 2654 0274 Email ID: [email protected] Website: www.pfizerindia.com

NOTICE

NOTICE is hereby given that pursuant to Section 124 of the Companies Act, 2013 ("the Act") read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Amendment Rules, 2017 ("the Rules") and other applicable provisions of the Act, if any, Pfizer Limited ("the Company") will credit the shares in respect of which dividend has remained unclaimed for seven consecutive years to the DEMAT Account of the Ministry of Corporate Affairs for the said purpose.

The Company has sent a reminder letter dated June 24, 2020, to the shareholders who have not claimed their dividend amount(s) for the seven consecutive years (i.e., from March 31, 2013 onwards) and intimated that failure to claim the same would lead to credit of their shares to the DEMAT Account of the Ministry of Corporate Affairs.

The concerned shareholders may note that upon credit of such shares to the said DEMAT Account, no claim shall lie against the Company in respect of unclaimed dividend amounts and such shares credited to DEMAT Account. Pursuant to the provisions of the Act and the Rules, the concerned shareholders can claim the transferred shares along with the unclaimed dividend amount(s) from the Ministry of Corporate Affairs. The procedure for claiming such dividend and/or shares are available at www.mca.gov.in and www.iepf.gov.in.

The details of shareholders who have not claimed their dividend for past seven years are uploaded on the Company's website at www.pfizerindia.com.

Further the shareholders who have not claimed any of their unclaimed dividend from March 31, 2013, are hereby requested to claim the same by sending a request letter along with copy of self-attested PAN Card, self-attested Proof of Address and cancelled cheque leaf to the Company's Registrar and Transfer Agent – Kfin Technologies Private Limited at [email protected] or the Company at [email protected].

We hereby further request to all shareholders to kindly update their e-mail ID, Bank Mandate and KYC details with their respective Depository Participants, if shares are held by them in electronic mode or with the Company, if the shares are held by them in Physical mode, in case if they have not updated the said details/information.

For any clarification/assistance, the concerned shareholder(s) may contact the Company's Registrar and Transfer Agent - Kfin Technologies Private Limited at [email protected] or the Company at [email protected].

For Pfizer Limited

Sd/-

Place: Mumbai Prajeet Nair Date: June 30, 2020 Company Secretary & Nodal Officer